The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial Revolution
Venus Remedies secures marketing authorization in Philippines
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Subscribe To Our Newsletter & Stay Updated
